Sanofi-Aventis Korea has extended the expiration date of its hemophilia A treatment Eloctate (efmoroctocog alfa) in Korea, following a controversy over mislabeling the drug's expiration date.Sanofi said Wednesday that it has received approval from the Ministry of Food and Drug Safety (MFSD) to exten
New drugs with different mechanisms of action have recently entered the ulcerative colitis (UC) treatment market in Korea, heralding fierce competition.Last Friday, the Ministry of Food and Drug Safety (MFDS) approved Lilly's interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab), giving Korean patien
SK chemicals said that it has decided not to proceed with the sale of its pharmaceutical business unit despite having previously signed a non-binding memorandum of understanding (MOU) with Glanwood Private Equity.SK chemicals' business divisions are divided into green chemicals, which produces eco-f
Huons' sales exceeded 500 billion won ($375 million) last year, thanks to increased pharmaceutical exports and efficient management of sales and management expenses.In a public filing on Wednesday, the company disclosed its preliminary consolidated operating results for 2023.According to the disclos
After posting strong growth last year, Boryung aims to continue its momentum this year and join the “Trillion Won Club.” The company's confidence is fueled by increased sales across all business areas and success in the anticancer area.Boryung CEO Chang Doo-hyun (Daniel Chang) recently met with repo
In a notable legal development, Hugel has secured a favorable outcome in its legal battles against the Ministry of Food and Drug Safety (MFDS) regarding the indirect export of Botulax, its botulinum toxin (BTX) products, which led to the revocation of its sales license. The Seoul Administrative Cour
Many Korean pharma and biotech companies posted record-breaking results last year. Still, those focusing on the vaccine business, including GC Biopharma and SK bioscience, performed relatively poorly as the Covid-19 pandemic eased to an endemic.According to GC Biopharma’s preliminary consolidated op
"Taking Sugatree is like catching two birds with one stone, as it offers both ease of administration and cost-effectiveness."Dong-A ST's employees at the Diabetes Division of the Marketing 2 team of the ETC Business Headquarters said so in unison.Sugatree XR Tablet is a diabetes treatment combinatio
Hanmi Pharm CEO Lim Jong-yoon, the eldest son of the late Lim Sung-ki, who founded the Hanmi Pharmaceutical Group, and his younger, Hanmi Science CEO Lim Jong-hoon, have announced their intention to change the management of Hanmi Science.They plan to form a new board of directors through the shareho
Handok said it decided to establish a local joint venture with Swedish Orphan Biovitrum (Sobi), a global biopharmaceutical company specializing in rare diseases, in the first half of this year.Sobi is a global biopharmaceutical company specializing in rare diseases, providing innovative treatments i
JW Pharmaceuticals announced on Tuesday that interim results from a study showcasing the efficacy and safety of Hemlibra (emicizumab) in hemophilia A patients younger than one year old were recently published in the international journal Blood.Dr. Steven Pipe, professor of pediatrics at the Universi
Hugel said it showcased new clinical findings for its botulinum toxin (BTX) product at the 25th International Master Course on Aging Science (IMCAS) World Congress, held in Paris, France, from Feb. 1 to 3.The event, which is recognized as the world's largest conference on aesthetic plastic surgery,
Tevimbra (tislelizumab), an anti-PD-1 immunotherapy developed by BeiGene, has begun the process of seeking reimbursement in Korea.BeiGene's stance of supplying innovative new drugs at reasonable prices is drawing attention to whether it could alleviate the growing financial burden caused by high-pri
Yuhan Corp. will hold its annual shareholders' meeting next month and decide whether to reappoint Cho Wook-je as its president and CEO. Industry officials watch with interest whether Cho will serve another term.The company issued a public notice last Tuesday, announcing that it would hold its annual
A new treatment has landed in Korea for moderate to severe active ulcerative colitis that has not responded adequately to standard treatments or biologics or has become unresponsive.Lilly Korea said Thursday that the interleukin-23 (IL-23) inhibitor Omvoh (mirikizumab) has received approval from the
Eutilex said Thursday that it has completed registering a patent for antibody therapy, “103,” in China.The patent for “103” was registered as "Anti-Human VSIG4 Antibody and Uses Thereof." Eutilex, which has completed patient registration in the U.S. and Russia, expects to expand its business territo
OCI Holdings Chairman Lee Woo-hyun has reaffirmed the company's strategy to play a minimal role in the management of Hanmi Group following the upcoming integration with Hanmi Science.During an investor conference call on Wednesday, Chairman Lee stated that OCI Holdings intends to support Hanmi Group
JW Pharmaceutical has posted record earnings in 2023, driven by increased sales of its hyperlipidemia drugs Livalo (pitavastatin) and LivaloZet and hemophilia drug Hemlibra.JW Pharmaceutical released its preliminary operating results for the past year through a disclosure of changes in sales or prof
GC Biopharma recorded disappointing results last year due to a decline in Covid-19-related demand and the slowing exports of Hunterase amid rising geopolitical risks.GC Biopharma released its preliminary consolidated operating results for 2023 by disclosing changes in sales or profit and loss struct
Yuhan Corp. said it posted highest-ever annual sales in 2023 thanks to technology export revenue.The company reported consolidated sales and operating profit of 1.8 trillion won ($1.3 billion) and 56.7 billion won in 2023, up 4.7 percent and 57.6 percent year-on-year. Net profit also jumped 57.4 per